Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis
Yıl: 2018 Cilt: 5 Sayı: 1 Sayfa Aralığı: 75 - 78 Metin Dili: İngilizce DOI: 10.5152/eurjrheum.2016.15081 İndeks Tarihi: 08-10-2019
Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis
Öz: The use of anti-tumor necrosis factor alpha (anti-TNF-α) agents has increased during the past decadein rheumatology practice. Opportunistic infections have been reported with anti-TNF-α agents inclinical trials and post-marketing usage. Aspergillus infection is a rare opportunistic infection that isassociated with immunosuppression, and there are reported cases of pulmonary aspergillosis in var-ious rheumatic diseases treated with anti-TNF-α agents. Here, we present the first case of pulmonaryaspergillosis associated with infliximab treatment in a patient with Still’s disease.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- Murdaca G, Colombo BM, Puppo F. Anti-TNF-al- pha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22: 557-65. [CrossRef]
- Tsiodras S, Samonis G, Boumpas DT, Kontoyian- nis DP. Fungal Infections Complicating Tumor Necrosis Factor-α. Mayo Clinic Proceedings 2008; 83: 181-94. [CrossRef]
- Salmon-Ceron D, Tubach F, Lortholary O, Cho- sidow O, Bretagne S, Nicolas N, et al. Drug-spe- cific risk of non-tuberculosis opportunistic in- fections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis 2011; 70: 616-23. [CrossRef]
- Al-Homood IA. Biologic treatments for adult-onset Still’s disease. Rheumatology 2014; 53: 32-8. [CrossRef]
- Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C. Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol 2001; 19: 329-32.
- Warris A, Bjorneklett A, Gaustad P. Invasive pul- monary aspergillosis associated with infliximab therapy. N Engl J Med 2001; 344: 1099-100. [CrossRef]
- Lee EJ, Song R, Park JN, Lee YA, Son JS, Hong SJ, et al. Chronic necrotizing pulmonary aspergil- losis in a patient treated with a tumor necrosis factor-α inhibitor. Int J Rheum Dis 2010; 13: 16- 9. [CrossRef]
- Larone DH. Medically Important Fungi. 5 th ed. Washington DC, ASM Press; 2011.
- Balajee SA, Houbraken J, Verweij PE, Hong SB, Yaghuchi T, Varga J, et al. Aspergillus species identification in the clinical setting. Stud Mycol 2007; 59: 39-46. [CrossRef]
- Nedel WL, Kontoyiannis DP, Pasqualotto AC. As- pergillosis in patients treated with monoclonal antibodies. Rev Iberoam Micol 2009; 26: 175-83. [CrossRef]
- Thompson GR 3rd, Patterson FP. Pulmonary aspergillosis. Semin Respir Crit Care Med. 2008; 29: 103-10. [CrossRef]
- Ho PL, Yuen KY. Aspergillosis in bone marrow transplant recipients. Crit Rev Oncol Hematol 2000; 34: 55-69. [CrossRef]
- Baddley JW. Clinical risk factors for invasive asper- gillosis. Med Mycol 2011; 49: 7-12. [CrossRef]
- Herbrecht R, Natarajan-Ame S, Letscher-Bru V, Can- uet M. Invasive pulmonary aspergillosis. Semin Re- spir Crit Care Med 2004; 25: 191-202. [CrossRef]
- Beaman L. Effects of recombinant gamma in- terferon and tumor necrosis factor on in-vitro interactions of human mononuclear phago- cytes with Coccidioides immitis. Infect Immun 1991; 59: 4227-9.
- Schelenz S, Smith DA, Bancroft GJ. Cytokine and chemokine responses following pulmonary chal- lenge with Aspergillus fumigatus: obligatory role of TNF-alpha and GM-CSF in neutrophil recruit- ment. Med Mycol 1999; 37: 183-94. [CrossRef]
- Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320-6. [CrossRef]
- Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803. [CrossRef]
- Caroli A, Fregonese D, Di Falco G, D’Incà R. As- pergillus fumigatus pneumonia during cyclo- sporine treatment for ulcerative colitis. Am J Gastroenterol 2000; 95: 3016-7. [CrossRef]
- Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive Hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003; 49: 633-9. [CrossRef]
| APA | ŞEYHOĞLU E, ERDEN A, Kılıç L, KARADAĞ Ö, Arikan-Akdagli S, AKDOĞAN A, KALYONCU U (2018). Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. , 75 - 78. 10.5152/eurjrheum.2016.15081 |
| Chicago | ŞEYHOĞLU Emrah,ERDEN Abdülsamet,Kılıç Levent,KARADAĞ ÖMER,Arikan-Akdagli Sevtap,AKDOĞAN Ali,KALYONCU Umut Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. (2018): 75 - 78. 10.5152/eurjrheum.2016.15081 |
| MLA | ŞEYHOĞLU Emrah,ERDEN Abdülsamet,Kılıç Levent,KARADAĞ ÖMER,Arikan-Akdagli Sevtap,AKDOĞAN Ali,KALYONCU Umut Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. , 2018, ss.75 - 78. 10.5152/eurjrheum.2016.15081 |
| AMA | ŞEYHOĞLU E,ERDEN A,Kılıç L,KARADAĞ Ö,Arikan-Akdagli S,AKDOĞAN A,KALYONCU U Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. . 2018; 75 - 78. 10.5152/eurjrheum.2016.15081 |
| Vancouver | ŞEYHOĞLU E,ERDEN A,Kılıç L,KARADAĞ Ö,Arikan-Akdagli S,AKDOĞAN A,KALYONCU U Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. . 2018; 75 - 78. 10.5152/eurjrheum.2016.15081 |
| IEEE | ŞEYHOĞLU E,ERDEN A,Kılıç L,KARADAĞ Ö,Arikan-Akdagli S,AKDOĞAN A,KALYONCU U "Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis." , ss.75 - 78, 2018. 10.5152/eurjrheum.2016.15081 |
| ISNAD | ŞEYHOĞLU, Emrah vd. "Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis". (2018), 75-78. https://doi.org/10.5152/eurjrheum.2016.15081 |
| APA | ŞEYHOĞLU E, ERDEN A, Kılıç L, KARADAĞ Ö, Arikan-Akdagli S, AKDOĞAN A, KALYONCU U (2018). Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. European Journal of Rheumatology, 5(1), 75 - 78. 10.5152/eurjrheum.2016.15081 |
| Chicago | ŞEYHOĞLU Emrah,ERDEN Abdülsamet,Kılıç Levent,KARADAĞ ÖMER,Arikan-Akdagli Sevtap,AKDOĞAN Ali,KALYONCU Umut Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. European Journal of Rheumatology 5, no.1 (2018): 75 - 78. 10.5152/eurjrheum.2016.15081 |
| MLA | ŞEYHOĞLU Emrah,ERDEN Abdülsamet,Kılıç Levent,KARADAĞ ÖMER,Arikan-Akdagli Sevtap,AKDOĞAN Ali,KALYONCU Umut Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. European Journal of Rheumatology, vol.5, no.1, 2018, ss.75 - 78. 10.5152/eurjrheum.2016.15081 |
| AMA | ŞEYHOĞLU E,ERDEN A,Kılıç L,KARADAĞ Ö,Arikan-Akdagli S,AKDOĞAN A,KALYONCU U Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. European Journal of Rheumatology. 2018; 5(1): 75 - 78. 10.5152/eurjrheum.2016.15081 |
| Vancouver | ŞEYHOĞLU E,ERDEN A,Kılıç L,KARADAĞ Ö,Arikan-Akdagli S,AKDOĞAN A,KALYONCU U Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis. European Journal of Rheumatology. 2018; 5(1): 75 - 78. 10.5152/eurjrheum.2016.15081 |
| IEEE | ŞEYHOĞLU E,ERDEN A,Kılıç L,KARADAĞ Ö,Arikan-Akdagli S,AKDOĞAN A,KALYONCU U "Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis." European Journal of Rheumatology, 5, ss.75 - 78, 2018. 10.5152/eurjrheum.2016.15081 |
| ISNAD | ŞEYHOĞLU, Emrah vd. "Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis". European Journal of Rheumatology 5/1 (2018), 75-78. https://doi.org/10.5152/eurjrheum.2016.15081 |
